Vital s.r.o.

The clinical trial activity at this hospital in Levice focuses on cardiovascular diseases, especially atherosclerotic cardiovascular disease. The research is centered on evaluating new ways to reduce serious heart, stroke, and blood vessel complications in people at high risk.

• Testing a new therapy aimed at lowering the risk of major cardiovascular events
• Studying treatment options for people with established ASCVD
• Assessing approaches to prevent heart attack, stroke, and urgent vascular problems

These studies are designed to improve treatment effectiveness and help better protect patients from severe cardiovascular outcomes.

This research site is also involved in trials exploring the connection between atherosclerotic cardiovascular disease, chronic kidney disease, and systemic inflammation. The goal is to determine whether targeted treatment can further reduce major cardiovascular risk in people with multiple overlapping conditions.

• Evaluating treatment effectiveness in patients with CKD and inflammation
• Investigating therapies for people with combined cardiovascular and kidney disease
• Measuring whether new approaches can lower the chance of major adverse heart events

At Ambulancia vnutorneho lekarstva, the emphasis is on advancing care for complex patients who may benefit from more precise prevention strategies.